{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:50:34Z","timestamp":1762159834520},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2002,10]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>Background and Purpose\u2014<\/jats:italic>\n            <\/jats:bold>\n            The fluorinated salicylate triflusal has been shown to have a neuroprotective effect after an excitotoxic lesion to the postnatal brain. In this regard, the aim of this study was to elucidate whether neuroprotection was associated with changes in the expression of proinflammatory molecules such as interleukin-1\u03b2 (IL-1\u03b2), tumor necrosis factor-\u03b1 (TNF-\u03b1), inducible nitric oxide synthase (iNOS), or cyclooxygenase-2 (COX-2), well-known mediators of oxidative stress and inflammation, mechanisms underlying secondary damage occurring after excitotoxic\/ischemic brain injury.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Methods\u2014<\/jats:italic>\n            <\/jats:bold>\n            Postnatal day 9 rats received an intracortical injection of\n            <jats:italic>N<\/jats:italic>\n            -methyl-\n            <jats:sc>d<\/jats:sc>\n            -aspartate followed by oral administration of triflusal (30 mg\/kg) 8 hours later. Ten or 24 hours after lesion, animals were killed, and brain sections processed for the immunohistochemical demonstration of IL-1\u03b2, TNF-\u03b1, iNOS, and COX-2.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Results\u2014<\/jats:italic>\n            <\/jats:bold>\n            Besides a reduction in the neurodegenerative area, triflusal strongly decreased iNOS immunolabeling at both survival times analyzed, attenuating iNOS immunoreactivity in astroglial cells and infiltrated neutrophils. Additionally, a moderate reduction in COX-2, IL-1\u03b2, and TNF-\u03b1 was observed. Triflusal decreased neuronal and microglial COX-2 expression at 10 and 24 hours after lesion and microglial and astroglial expression of IL-1\u03b2 and TNF-\u03b1 at 24 hours after lesion. TNF-\u03b1 expression in neuronal cells at 10 hours after lesion was, however, maintained.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Conclusions\u2014<\/jats:italic>\n            <\/jats:bold>\n            This study suggests that triflusal neuroprotection is associated with a decrease of iNOS and other inflammatory mediators and therefore may constitute a good therapeutic agent in pathological situations in which regulation of inflammatory genes constitutes a relevant step in the outcome of the neurodegenerative event.\n          <\/jats:p>","DOI":"10.1161\/01.str.0000028184.80776.58","type":"journal-article","created":{"date-parts":[[2002,10,3]],"date-time":"2002-10-03T22:27:27Z","timestamp":1033684047000},"page":"2499-2505","update-policy":"http:\/\/dx.doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":34,"title":["Decrease of Proinflammatory Molecules Correlates With Neuroprotective Effect of the Fluorinated Salicylate Triflusal After Postnatal Excitotoxic Damage"],"prefix":"10.1161","volume":"33","author":[{"given":"Laia","family":"Acarin","sequence":"first","affiliation":[{"name":"From the Unit of Histology, School of Medicine, Department of Cell Biology, Physiology, and Immunology, Autonomous University of Barcelona, Bellaterra, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berta","family":"Gonza\u0301lez","sequence":"additional","affiliation":[{"name":"From the Unit of Histology, School of Medicine, Department of Cell Biology, Physiology, and Immunology, Autonomous University of Barcelona, Bellaterra, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo","family":"Castellano","sequence":"additional","affiliation":[{"name":"From the Unit of Histology, School of Medicine, Department of Cell Biology, Physiology, and Immunology, Autonomous University of Barcelona, Bellaterra, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199855060-00011"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.32.10.2394"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(96)10074-6"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevNeurobiol.v13.i1.30"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(97)00052-X"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(98)00034-3"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0736-5748(95)00018-C"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","unstructured":"Morganti-Kossmann MA Kossmann T. The immunology of brain injury.In: Rothwell N ed. Immune Responses in the Nervous System. Oxford UK: BIOS Scientific Publishers Inc; 1995: 159\u2013187.","DOI":"10.1093\/acprof:oso\/9781872748795.003.0008"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199610000-00015"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.26.6.1093"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1046\/j.1471-4159.1996.67052215.x","volume":"67","year":"1996","unstructured":"Hagan P, Poole S, Bristow AF, Tilders F, Silverstein FS. Intracerebral NMDA injection stimulates production of interleukin-1 beta in perinatal rat brain. J Neurochem. 1996; 67: 2215\u20132218.","journal-title":"J Neurochem"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2000.00226.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2000.tb01316.x"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1046\/j.1471-4159.1998.70062516.x","volume":"70","year":"1998","unstructured":"Coeroli L, Renolleau S, Arnaud S, Plotkine D, Cachin N, Plotkine M, Ben-Ari Y, Charriaut-Marlangue C. Nitric oxide production and perivascular tyrosine nitration following focal ischemia in neonatal rat. J Neurochem. 1998; 70: 2516\u20132525.","journal-title":"J Neurochem"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-3806(98)00022-4"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.10261"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","unstructured":"Szab\u00f3 C. Pathophysiological roles of nitric oxide in inflammation.In: Ignarro LJ ed. Nitric Oxide. New York NY: Academic Press; 2000: 841\u2013872.","DOI":"10.1016\/B978-012370420-7\/50053-8"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevNeurobiol.v10.i3-4.20"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(98)00331-5"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(99)00022-6"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1997.6593"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702441"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199709290-00031"},{"key":"e_1_3_2_24_2","first-page":"R286","volume":"268","year":"1995","unstructured":"Iadecola C, Zhang F, Xu X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol. 1995; 268: R286\u2013R292.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(08)63213-6"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.28.6.1283"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.4.1620"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1996.271.5.C1424"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(94)90362-X"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/34923"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702119"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-23-09157.1997"},{"key":"e_1_3_2_33_2","first-page":"753","volume":"55","year":"1999","unstructured":"Fern\u00e1ndez de Arriba A, Cavalcanti F, Miralles A, Bay\u00f3n Y, Alonso A, Merlos M, Garcia-Rafanell J, Forn J. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid. Mol Pharmacol. 1999; 55: 753\u2013760.","journal-title":"Mol Pharmacol"},{"key":"e_1_3_2_34_2","first-page":"417","volume":"293","year":"2000","unstructured":"Hewett SJ, Uliasz TF, Vidwans AS, Hewett JA. Cyclooxygenase-2 contributes to N-methyl-d-aspartate-mediated neuronal cell death in primary cortical cell culture. J Pharmacol Exp Ther. 2000; 293: 417\u2013425.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-08-02746.1997"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65199-1"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.98.3.1294"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.12.6500"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-0618(00)00081-8"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(96)01035-1"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(94)90159-7"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(98)00045-8"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.1999.003af.x"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.STR.0000028184.80776.58","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T20:22:20Z","timestamp":1715545340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.STR.0000028184.80776.58"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["10.1161\/01.STR.0000028184.80776.58"],"URL":"https:\/\/doi.org\/10.1161\/01.str.0000028184.80776.58","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]},"assertion":[{"value":"2001-12-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-05-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-10-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}